Jongmin Hwang
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: April 20, 2026
Edoxaban Antithrombotic Therapy in Diabetic Patients with Atrial Fibrillation and Stable Coronary Artery Disease: The EPIC-CAD Trial.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: February 23, 2026
Clinical Outcomes of High Density Voltage and Fractionation Mapping-Guided Ablation in Patients With Persistent Atrial Fibrillation.
Journal: Journal of arrhythmia
Published: February 05, 2026
Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial.
Journal: Heart (British Cardiac Society)
Published: June 15, 2025
Late stent strut apposition and coverage after drug-eluting stent implantation by optical coherence tomography in patients with acute myocardial infarction.
Journal: Coronary artery disease
Published: May 27, 2025
Long-Term Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior PCI: Insights From EPIC-CAD Trial.
Journal: Journal of the American College of Cardiology
Published: May 26, 2025
Resolution of Thrombi in Left Atrial Appendage With Edoxaban: Results of the 'REFLEX' Study.
Journal: JACC. Asia
Published: December 11, 2024
Safety and Performance of the Micra VR Leadless Pacemaker in a South Korean Cohort: A Comparison to Global Studies.
Journal: Korean circulation journal
Published: September 20, 2024
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
Journal: The New England journal of medicine
Published: September 03, 2024
Last Updated: 09/26/2026